A

Alnylam Pharma (ALNY)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Alnylam Pharma (ALNY)

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of ribonucleic acid (RNA) interference (RNAi) therapeutics. The Company is focused on the use of its N-acetylgala... Read more

Open
USD267.40
High
USD268.07
Low
USD261.45
52 Week High
USD304.39
Monthly Return
13.60%
Revenue
2.3B

Daily Vol.
227.34k
Avg. Daily Vol.
965.98k
Market Cap.
32.7B
52 Week Low
144.73
Annual Return
79.60%

Stock News

Crypto broker eToro’s IPO to test the waters for stock-market newcomers

Crypto broker eToro’s IPO to test the waters for stock-market newcomers

MarketWatch

U.S.-China trade war pushed global supply chain near breaking point, new data shows

U.S.-China trade war pushed global supply chain near breaking point, new data shows

CNBC

Op-ed: What comes next in U.S.-China trade talks should give us all pause

Op-ed: What comes next in U.S.-China trade talks should give us all pause

CNBC

I lost $500 getting scammed on Facebook Marketplace: 4 red flags I shouldn't have ignored

I lost $500 getting scammed on Facebook Marketplace: 4 red flags I shouldn't have ignored

CNBC

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.